0 Kommentare
0 Geteilt
320 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Antisense Oligonucleotide for Genetic and Rare Disorders Market: Next-Generation Therapeutic InnovationsAccording to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Genetic and Rare Disorders Market CAGR Value The global antisense oligonucleotide for genetic and rare disorders market size was valued at USD 529.26 billion in 2024 and is expected to reach USD 1,563.55 billion by 2032, at a CAGR of...0 Kommentare 0 Geteilt 236 Ansichten 0 Bewertungen
-
Antisense Oligonucleotide Market for Neuromuscular Disorders to Expand with Advances in RNA-Targeted Therapies" According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Neuromuscular Disorders Market CAGR Value The global antisense oligonucleotide for neuromuscular disorders market size was valued at USD 2.03 billion in 2024 and is expected to reach USD 4.87 billion by 2032, at a CAGR of 11.50% during the...0 Kommentare 0 Geteilt 77 Ansichten 0 Bewertungen
-
Lipoprotein(a)-Targeted RNA Therapeutics Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Lipoprotein(a)-Targeted RNA Therapeutics Market The Lipoprotein(a)-Targeted RNA Therapeutics Market was valued at USD 1.68 billion in 2025 and is projected to reach USD 7.17 billion by 2033, growing at a CAGR of 19.90% from 2026 to 2033. The market is witnessing strong growth driven by...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen